ATXS
Astria Therapeutics Inc

11,105
Mkt Cap
$747.24M
Volume
301,516.00
52W High
$13.29
52W Low
$3.56
PE Ratio
-6.09
ATXS Fundamentals
Price
$13.09
Prev Close
$12.99
Open
$13.00
50D MA
$12.66
Beta
1.18
Avg. Volume
1.06M
EPS (Annual)
-$1.68
P/B
5.36
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Astria Therapeutics, Inc. (NASDAQ:ATXS) Given Average Recommendation of "Hold" by Brokerages
Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) has been given a consensus recommendation of "Hold" by the eleven brokerages that are presently covering the stock, MarketBeat Ratings...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ATXS, MBCN, FMNB, and SEMR
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ATXS, MBCN, FMNB, and SEMR $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ATXS...
PR Newswire·13d ago
News Placeholder
Astria Therapeutics, Inc. $ATXS Shares Acquired by JPMorgan Chase & Co.
JPMorgan Chase & Co. boosted its position in Astria Therapeutics, Inc. (NASDAQ:ATXS - Free Report) by 4,607.1% during the second quarter, according to its most recent 13F filing with the Securities...
MarketBeat·22d ago
News Placeholder
Panagora Asset Management Inc. Purchases New Holdings in Astria Therapeutics, Inc. $ATXS
Panagora Asset Management Inc. acquired a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing...
MarketBeat·25d ago
News Placeholder
Astria Therapeutics (NASDAQ:ATXS) Sees Large Volume Increase - What's Next?
Astria Therapeutics (NASDAQ:ATXS) Sees Large Volume Increase - Here's What Happened...
MarketBeat·28d ago
News Placeholder
Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives Average Rating of "Hold" from Analysts
Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) have been given an average recommendation of "Hold" by the eleven analysts that are currently covering the firm, MarketBeat...
MarketBeat·28d ago
News Placeholder
Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to...
PR Newswire·1mo ago
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX...
PR Newswire·1mo ago
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-SPNS, PCH, ATXS, and RYN
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-SPNS, PCH, ATXS, and RYN $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-SPNS, PCH...
PR Newswire·1mo ago
News Placeholder
Bailard Inc. Buys New Shares in Astria Therapeutics, Inc. $ATXS
Bailard Inc. acquired a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·2mo ago
<
1
2
...
>

Latest ATXS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.